Psych Congress
Digital medicine system may reduce schizophrenia symptoms
A digital medicine system appeared to improve clinical schizophrenia symptoms beyond the effects of oral pharmacotherapy alone, according to study results presented at Psych Congress.
Psychiatric physician assistant workforce grew significantly in recent years
The number of physician assistants in the psychiatric workforce grew significantly between 2015 and 2020, according to study results presented at Psych Congress.
Schizophrenia burden totaled more than $340 billion in 2019
Schizophrenia’s approximate societal burden was $341.5 billion in the U.S. in 2019, according to study results presented at Psych Congress.
Many older adults use sleep medications every night
Older adults frequently used medication to treat sleep difficulties, according to study results presented at Psych Congress.
Social determinants of health adversely affect outcomes in severe mental illness
Patients with severe mental illness, particularly those with schizophrenia who are insured by Medicaid, have significant social risk factors that may adversely affect overall health, according to a study presented at Psych Congress.
Most LAI antipsychotic prescribers report pandemic has not affected prescribing
Most frequent prescribers of long-acting injectable antipsychotics reported no changes in prescribing during the COVID-19 pandemic, according to results of a health care provider survey study presented at Psych Congress.
Expert highlights interventions for OCD-linked internet, gaming, sex addictions
Excessive behaviors related to internet, gaming and sex that may be linked to obsessive-compulsive disorder lack a clear treatment approach and thus warrant consideration of various factors, according to a presenter at Psych Congress.
Benefits of treating perinatal anxiety disorders ‘greatly outweigh’ risks
Untreated perinatal anxiety disorders and related stress or depression among mothers pose risks to offspring, according to a presenter at Psych Congress.